Anti-Human EGFR Recombinant Antibody(Zalutumumab)
-
产品编号
YR1134
-
别名
科研级 Zalutumumab ( 扎芦木单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Zalutumumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Zalutumumab ( 扎芦木单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Zalutumumab |
Catalog Number | YR1134 |
Molecular Name | Zalutumumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. |
CAS Number | 667901-13-5 |
Application | ELISA, FCM, IP, FuncS, IF, Neut |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 146.64 kDa |
Target | EGFR[Homo sapiens] |